Matches in Wikidata for { <http://www.wikidata.org/entity/Q59328213> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q59328213 description "article" @default.
- Q59328213 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59328213 description "wetenschappelijk artikel" @default.
- Q59328213 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q59328213 name "541. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment Naïve Patients: Week 48 Results in Subgroups Based on Baseline Viral Load, CD4+ Count, and WHO Clinical Staging" @default.
- Q59328213 name "541. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment Naïve Patients: Week 48 Results in Subgroups Based on Baseline Viral Load, CD4+ Count, and WHO Clinical Staging" @default.
- Q59328213 type Item @default.
- Q59328213 label "541. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment Naïve Patients: Week 48 Results in Subgroups Based on Baseline Viral Load, CD4+ Count, and WHO Clinical Staging" @default.
- Q59328213 label "541. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment Naïve Patients: Week 48 Results in Subgroups Based on Baseline Viral Load, CD4+ Count, and WHO Clinical Staging" @default.
- Q59328213 prefLabel "541. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment Naïve Patients: Week 48 Results in Subgroups Based on Baseline Viral Load, CD4+ Count, and WHO Clinical Staging" @default.
- Q59328213 prefLabel "541. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment Naïve Patients: Week 48 Results in Subgroups Based on Baseline Viral Load, CD4+ Count, and WHO Clinical Staging" @default.
- Q59328213 P1433 Q59328213-62B43F92-93BC-44E2-91FF-DCD2797D57CA @default.
- Q59328213 P1476 Q59328213-005682B5-23C6-4AE8-ACCD-61561333FC5E @default.
- Q59328213 P2093 Q59328213-0D92F50B-F6FC-4D21-9A76-AA66FAA69739 @default.
- Q59328213 P2093 Q59328213-3640CD80-7A47-4761-82B4-075EF3F76B4A @default.
- Q59328213 P2093 Q59328213-38C06DB5-F9A7-4E6F-A7D9-74979EF0D575 @default.
- Q59328213 P2093 Q59328213-667C515C-88F7-45A5-B12F-355A364B3AFF @default.
- Q59328213 P2093 Q59328213-6A0CC76D-AAB6-4F34-90E2-178FB646CE86 @default.
- Q59328213 P2093 Q59328213-8E3F539A-EE37-4869-AC60-01BF7E0DE679 @default.
- Q59328213 P2093 Q59328213-A0CEA19F-6C8C-4968-A0E4-6A88FCA467A7 @default.
- Q59328213 P2093 Q59328213-EE693C51-FC75-4FCD-93FD-BE86F353D40D @default.
- Q59328213 P275 Q59328213-6693c1db-ca05-4d8d-9fa5-4fc4780b255f @default.
- Q59328213 P304 Q59328213-EA43AC8B-F2E9-4B17-BA88-761CE05BA6F1 @default.
- Q59328213 P31 Q59328213-3DF7EB32-4FBA-4985-93C5-7E321700E028 @default.
- Q59328213 P356 Q59328213-07DFFD58-2EF5-4FF4-98DD-67DEF48321AA @default.
- Q59328213 P433 Q59328213-A2224387-9C20-49C0-9C33-950F49761866 @default.
- Q59328213 P478 Q59328213-C61D12E4-AF5D-45B4-9D3D-67E6BF98AFE0 @default.
- Q59328213 P577 Q59328213-DE48CE30-0567-40CA-9845-6550187E3349 @default.
- Q59328213 P6216 Q59328213-3d206f8f-f38a-4ab5-bc4d-5f2b0c1b005f @default.
- Q59328213 P921 Q59328213-0C10FEEE-9276-420B-8523-E8F8EB895669 @default.
- Q59328213 P921 Q59328213-64A2941E-3272-41A4-BBAE-13703A08B812 @default.
- Q59328213 P921 Q59328213-B7496859-DEF4-4BDA-96A8-F858DD8384ED @default.
- Q59328213 P932 Q59328213-55850269-9B88-4AA1-B400-BC89EC77968F @default.
- Q59328213 P356 OFY210.550 @default.
- Q59328213 P1433 Q27725953 @default.
- Q59328213 P1476 "541. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment Naïve Patients: Week 48 Results in Subgroups Based on Baseline Viral Load, CD4+ Count, and WHO Clinical Staging" @default.
- Q59328213 P2093 "Bruce Rashbaum" @default.
- Q59328213 P2093 "Cheryl Mcdonald" @default.
- Q59328213 P2093 "Christoph D Spinner" @default.
- Q59328213 P2093 "Cristina Mussini" @default.
- Q59328213 P2093 "Donghan Luo" @default.
- Q59328213 P2093 "Eric Y Wong" @default.
- Q59328213 P2093 "John Jezorwski" @default.
- Q59328213 P2093 "Kimberley Brown" @default.
- Q59328213 P275 Q24082749 @default.
- Q59328213 P304 "S201-S201" @default.
- Q59328213 P31 Q13442814 @default.
- Q59328213 P356 "10.1093/OFID/OFY210.550" @default.
- Q59328213 P433 "suppl_1" @default.
- Q59328213 P478 "5" @default.
- Q59328213 P577 "2018-11-01T00:00:00Z" @default.
- Q59328213 P6216 Q50423863 @default.
- Q59328213 P921 Q155954 @default.
- Q59328213 P921 Q2528140 @default.
- Q59328213 P921 Q422604 @default.
- Q59328213 P932 "6253519" @default.